By Jim Woods The Columbus Dispatch Monday May 20, 2013 4:56 AM Dr. Ernest L. Mazzaferri Sr. became the first in his family to attend high school, going on to become a renowned expert in thyroid cancer treatment at the Ohio State University College of Medicine during the 1980s and ’90s. Mazzaferri, 76, who was living in retirement in Henderson, Nev., died on Tuesday at his home in hospice care after suffering a stroke, said
(More)…
By Jim Woods The Columbus Dispatch Monday May 20, 2013 4:56 AM Dr. Ernest L. Mazzaferri Sr. became the first in his family to attend high school, going on to become a renowned expert in thyroid cancer treatment at the Ohio State University College of Medicine during the 1980s and ’90s. Mazzaferri, 76, who was living in retirement in Henderson, Nev., died on Tuesday at his home in hospice care after suffering a stroke, said
(More)…
PUYALLUP, Wash.– Emerald Ridge High School cheer coach Kaitie Johnson has good reason to count her blessings. The young woman was sidelined by a cancer diagnosis, but she is alive today thanks to a new drug developed by Seattle Genetics in Bothell. The former cheerleader now a coach at her alma mater, says she’s also alive thanks in part to the team. “I was diagnosed the summer before my senior year,” she said. In 2009,
(More)…
PUYALLUP, Wash.– Emerald Ridge High School cheer coach Kaitie Johnson has good reason to count her blessings. The young woman was sidelined by a cancer diagnosis, but she is alive today thanks to a new drug developed by Seattle Genetics in Bothell. The former cheerleader now a coach at her alma mater, says she’s also alive thanks in part to the team. “I was diagnosed the summer before my senior year,” she said. In 2009,
(More)…
For More Information Those interested in more information about the BRCA mutation can contact the San Juan Regional Medical Center’s Cancer Navigator at 505-609-6259. Additional information about support and resources available to those diagnosed with BRCA is available at www.brightpink.com. FARMINGTON — Last week, Angelina Jolie announced that she had undergone a double mastectomy after learning she had inherited a cancer-causing genetic mutation. In light of the news, one local woman and her mother —
(More)…
For More Information Those interested in more information about the BRCA mutation can contact the San Juan Regional Medical Center’s Cancer Navigator at 505-609-6259. Additional information about support and resources available to those diagnosed with BRCA is available at www.brightpink.com. FARMINGTON — Last week, Angelina Jolie announced that she had undergone a double mastectomy after learning she had inherited a cancer-causing genetic mutation. In light of the news, one local woman and her mother —
(More)…
TOLEDO, Ohio – The wait for answers is far from over for parents who for years have lived with the worry of not knowing what’s behind the mysterious cancers that have sickened dozens of children in a rural area of northern Ohio. Despite a federal civil lawsuit that points toward a possible cause, the issue is far from settled. Not much is known about the chemical compound detected by environmental testing in the attics of
(More)…
TOLEDO, Ohio – The wait for answers is far from over for parents who for years have lived with the worry of not knowing what’s behind the mysterious cancers that have sickened dozens of children in a rural area of northern Ohio. Despite a federal civil lawsuit that points toward a possible cause, the issue is far from settled. Not much is known about the chemical compound detected by environmental testing in the attics of
(More)…
Advances in genetic profiling have allowed doctors to match more of their cancer patients with treatments that will target their particular illnesses. But for some about one-third of cancer patients, there are no good matches, leaving them with only conventional chemotherapies and radiation. Now Dr. Keith T. Flaherty, an oncologist, and his colleagues at Massachusetts General Hospital have developed a more sophisticated formula for analyzing tumors to find their vulnerabilities. On Monday, the hospital will
(More)…
Advances in genetic profiling have allowed doctors to match more of their cancer patients with treatments that will target their particular illnesses. But for some about one-third of cancer patients, there are no good matches, leaving them with only conventional chemotherapies and radiation. Now Dr. Keith T. Flaherty, an oncologist, and his colleagues at Massachusetts General Hospital have developed a more sophisticated formula for analyzing tumors to find their vulnerabilities. On Monday, the hospital will
(More)…